Hyderabad-based Suven Life Sciences announced that it has started Phase I clinical trial of its experimental drug for treating Alzheimer's and schizophrenia. The company revealed that it has submitted the data for Investigational New Drug Application with the US Food and Drug Administration after wrapping up all the pre-clinical, safety and early toxicological studies. The approval will provide it with the authorization to conduct the Phase 1 clinical trial ...
Read More
You have just read an article categorized health
titled Suven Life Sciences Starts Phase I Trial for Alzheimer's Drug.
Written by:
editor -
Tuesday, November 4, 2014
There are currently no comments for "Suven Life Sciences Starts Phase I Trial for Alzheimer's Drug"
Post a Comment